Biointaxis
Spinout from the Igtp for neurodegenerative rare diseases.
Biointaxis has raised €3.0M across 3 funding rounds from 5 investors. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainbiointaxis.com ↗
Total raised
€3.0M
€3,050,000
Funding rounds
3
Investors
5
distinct backers
Active since
2021-11
Funding by year
EUR raised per yearBiointaxis — funding by year — interactive chart.
Data table
| Biointaxis — funding by year | |
|---|---|
| 2021 | €880k |
| 2024 | €2.2M |
Signals
High confidenceRaise-next likelihood29
base rate 30% for Other
- ▼ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| — | Other | — | — | View deal → |
| 2024-10-23 | Other | €2.2M | European Commission,Ministry of Science, Innovation and Universities | View deal → |
| 2021-11-03 | Other | €880k | Antonio Parente,Capital Cell,Private Investors | View deal → |
Investors
5Related news
- Biointaxis cierra a través de Capital Cell una ronda de €880.000webcapitalriesgo.com · 2021-11
- elreferente.es
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData